论文信息 - Specific scoring systems to predict survival of patients with high-risk myelodysplastic syndrome (MDS) and de novo acute myeloid leukemia (AML) after intensive antileukemic treatment based on results of the EORTC-GIMEMA AML-10 and intergroup CRIANT studies - 字舞流文

Specific scoring systems to predict survival of patients with high-risk myelodysplastic syndrome (MDS) and de novo acute myeloid leukemia (AML) after intensive antileukemic treatment based on results of the EORTC-GIMEMA AML-10 and intergroup CRIANT studies

M. Vignetti | F. Mandelli | R. Willemze | E. Hellström-Lindberg | M. Oosterveld | U. Germing | M. Delforge | B. Labar | S. Suciu | S. Amadori | T. Witte | A. Ferrant | U. Jehn | C. Aul | P. Muus | D. Selleslag | J. Marie | A. Belhabri | U. Hess | Songuel Cakmak-Wollgast